Recent guidelines are right to recommend screening high risk patients for liver cirrhosis, say Mark Hudson and Nick Sheron. But Ian Rowe and Gideon Hirschfield worry about the lack of a suitable screening test
No takes yet. Share an insight, caveat, or question.
Hudson et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: